Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ.

Cell Stem Cell. 2010 Nov 5;7(5):618-30. doi: 10.1016/j.stem.2010.08.012. Epub 2010 Sep 30.

2.

Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.

Sridhar A, Ohlemacher SK, Langer KB, Meyer JS.

Stem Cells Transl Med. 2016 Apr;5(4):417-26. doi: 10.5966/sctm.2015-0093. Epub 2016 Mar 1.

3.

Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).

Singh VK, Kumar N, Kalsan M, Saini A, Chandra R.

J Stem Cells. 2015;10(1):43-62. Review.

PMID:
26665937
4.

Reprogramming human fibroblasts to pluripotency using modified mRNA.

Mandal PK, Rossi DJ.

Nat Protoc. 2013 Mar;8(3):568-82. doi: 10.1038/nprot.2013.019. Epub 2013 Feb 21.

PMID:
23429718
5.

Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming.

Rony IK, Baten A, Bloomfield JA, Islam ME, Billah MM, Islam KD.

Cell Prolif. 2015 Apr;48(2):140-56. doi: 10.1111/cpr.12162. Epub 2015 Jan 29. Review.

PMID:
25643745
6.

Synthetic mRNA Reprogramming of Human Fibroblast Cells.

Liu J, Verma PJ.

Methods Mol Biol. 2015;1330:17-28. doi: 10.1007/978-1-4939-2848-4_2.

PMID:
26621585
7.

Engineering cell fate: Spotlight on cell-activation and signaling-directed lineage conversion.

Ebrahimi B.

Tissue Cell. 2016 Oct;48(5):475-87. doi: 10.1016/j.tice.2016.07.005. Epub 2016 Jul 26. Review.

PMID:
27514850
8.
9.

A practical and efficient cellular substrate for the generation of induced pluripotent stem cells from adults: blood-derived endothelial progenitor cells.

Geti I, Ormiston ML, Rouhani F, Toshner M, Movassagh M, Nichols J, Mansfield W, Southwood M, Bradley A, Rana AA, Vallier L, Morrell NW.

Stem Cells Transl Med. 2012 Dec;1(12):855-65. doi: 10.5966/sctm.2012-0093. Epub 2012 Nov 29.

10.

Cell type of origin influences iPSC generation and differentiation to cells of the hematoendothelial lineage.

Phetfong J, Supokawej A, Wattanapanitch M, Kheolamai P, U-Pratya Y, Issaragrisil S.

Cell Tissue Res. 2016 Jul;365(1):101-12. doi: 10.1007/s00441-016-2369-y. Epub 2016 Feb 19.

PMID:
26893154
11.

MicroRNA-302 increases reprogramming efficiency via repression of NR2F2.

Hu S, Wilson KD, Ghosh Z, Han L, Wang Y, Lan F, Ransohoff KJ, Burridge P, Wu JC.

Stem Cells. 2013 Feb;31(2):259-68. doi: 10.1002/stem.1278.

12.

Cell fate conversion by mRNA.

Li M, Sancho-Martinez I, Izpisua Belmonte JC.

Stem Cell Res Ther. 2011 Feb 9;2(1):5. doi: 10.1186/scrt46.

13.

A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.

Moad M, Pal D, Hepburn AC, Williamson SC, Wilson L, Lako M, Armstrong L, Hayward SW, Franco OE, Cates JM, Fordham SE, Przyborski S, Carr-Wilkinson J, Robson CN, Heer R.

Eur Urol. 2013 Nov;64(5):753-61. doi: 10.1016/j.eururo.2013.03.054. Epub 2013 Apr 6.

14.

Induced pluripotency and direct reprogramming: a new window for treatment of neurodegenerative diseases.

Li R, Bai Y, Liu T, Wang X, Wu Q.

Protein Cell. 2013 Jun;4(6):415-24. doi: 10.1007/s13238-013-2089-y. Epub 2013 May 20. Review.

15.

Purification of functional reprogramming factors in mammalian cell using FLAG -Tag.

Han MJ, Kim HR, O'Reilly C, Kim CH.

Biochem Biophys Res Commun. 2017 Oct 14;492(2):154-160. doi: 10.1016/j.bbrc.2017.08.028. Epub 2017 Aug 9.

16.

Generation of human β-thalassemia induced pluripotent cell lines by reprogramming of bone marrow-derived mesenchymal stromal cells using modified mRNA.

Varela I, Karagiannidou A, Oikonomakis V, Tzetis M, Tzanoudaki M, Siapati EK, Vassilopoulos G, Graphakos S, Kanavakis E, Goussetis E.

Cell Reprogram. 2014 Dec;16(6):447-55. doi: 10.1089/cell.2014.0050. Epub 2014 Oct 29.

PMID:
25354259
17.

Reprogramming Enhancers in Somatic Cell Nuclear Transfer, iPSC Technology, and Direct Conversion.

Kwon D, Ji M, Lee S, Seo KW, Kang KS.

Stem Cell Rev. 2017 Feb;13(1):24-34. doi: 10.1007/s12015-016-9697-x. Review.

PMID:
27817181
18.

Reprogramming of mouse and human cells to pluripotency using mature microRNAs.

Miyoshi N, Ishii H, Nagano H, Haraguchi N, Dewi DL, Kano Y, Nishikawa S, Tanemura M, Mimori K, Tanaka F, Saito T, Nishimura J, Takemasa I, Mizushima T, Ikeda M, Yamamoto H, Sekimoto M, Doki Y, Mori M.

Cell Stem Cell. 2011 Jun 3;8(6):633-8. doi: 10.1016/j.stem.2011.05.001.

19.

The Effect of Fetal Bovine Serum (FBS) on Efficacy of Cellular Reprogramming for Induced Pluripotent Stem Cell (iPSC) Generation.

Kwon D, Kim JS, Cha BH, Park KS, Han I, Park KS, Bae H, Han MK, Kim KS, Lee SH.

Cell Transplant. 2016;25(6):1025-42. doi: 10.3727/096368915X689703. Epub 2015 Oct 7.

PMID:
26450367
20.

Induced pluripotent stem cells and senescence: learning the biology to improve the technology.

Banito A, Gil J.

EMBO Rep. 2010 May;11(5):353-9. doi: 10.1038/embor.2010.47. Epub 2010 Apr 9.

Supplemental Content

Support Center